The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance

Area of Science:

• Biochemistry
• Molecular Biology
• Cellular Metabolism

Background:

• Protein tyrosine phosphatase 1B (PTP1B) is a key regulator of insulin signaling, dephosphorylating the insulin receptor and IRS-1, thus terminating insulin signaling.
• O-GlcNAc modification is increasingly recognized for its role in regulating components of the insulin signaling pathway.

Purpose of the Study:

• To investigate the role of O-GlcNAcylation of PTP1B in hepatic insulin resistance.
• To determine how palmitate acid (PA) affects PTP1B O-GlcNAcylation and insulin signaling.

Main Methods:

• Identified O-GlcNAc modification sites on PTP1B (Ser104, Ser201, Ser386).
• Utilized HepG2 cells treated with palmitate acid to induce insulin resistance.
• Employed site-directed gene mutation to interfere with PTP1B O-GlcNAcylation.
• Assessed insulin signaling by measuring phosphorylation of Akt and GSK3β.

Main Results:

• Palmitate acid upregulated PTP1B O-GlcNAcylation and impaired insulin signaling, evidenced by decreased Akt and GSK3β phosphorylation.
• Intervention of PTP1B O-GlcNAcylation via gene mutation inhibited PTP1B phosphatase activity.
• Mutated PTP1B led to increased Akt and GSK3β phosphorylation, improved insulin sensitivity, and reduced lipid deposition in HepG2 cells.

Conclusions:

• O-GlcNAcylation of PTP1B modulates its phosphatase activity, influencing insulin signal transduction.
• This modification plays a significant role in the development of hepatic insulin resistance.
• Targeting PTP1B O-GlcNAcylation presents a potential therapeutic strategy for metabolic disorders.